Clinical Trial

Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis

Name: Teclistamab in Newly Diagnosed Mayo Stage IIIB AL Amyloidosis — clinical trial record (NCT07079423)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a phase II study in patients with newly diagnosed Mayo stage IIIB immunoglobulin light-chain (AL) Amyloidosis to evaluate the efficacy and safety of teclistamab

Trial Details

NCT Number	NCT07079423
Lead Sponsor	Peking Union Medical College Hospital
Conditions	AL Amyloidosis
Enrollment	35 participants
Start Date	2025-06-28
Primary Completion	2027-01-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-23